Mastodynia elimination at hormonal treatment of patients with uterine myoma

High frequency (at 54,2%) of combination of uterine fi broids and benign mammary dysplasia may be due to their common etiology and pathogenesis. A large amount of literature data that based on clinical studies show the eff ectiveness of herbal and homeopathic medicines in treatment of mastitis, that is especially important in their nomination in patients with uterine myoma. Agnus castus is the most studied among the medicinal plants that have affi nity for the neuroendocrine system of a human and preparations on the basis of which (including Mastodynon) is eff ectively used for the treatment of latent hyperprolactinemia and mastodynia, premenstrual and menopausal syndromes. Studies have shown that Mastodynon helps to reduce the pain associated with mastitis and premenstrual syndrome, and also reduces the swelling of the glandular component, so it can be recommended for the treatment of diff use form of mammary dysplasia. Mastodynon is also possible to use during the course of hormonal therapy in patients with uterine myoma to ensure maximum safety and comfort for the patient treatment process